Attachment of phosphorylcholine residues to pneumococcal teichoic acids and modification of substitution patterns by the phosphorylcholine esterase

The Journal of Biological Chemistry
Franziska WaldowNicolas Gisch

Abstract

The bacterial lung pathogen Streptococcus pneumoniae has a unique nutritional requirement for exogenous choline and attaches phosphorylcholine (P-Cho) residues to the GalpNAc moieties of its teichoic acids (TAs) in its cell wall. Two phosphorylcholine transferases, LicD1 and LicD2, mediate the attachment of P-Cho to the O-6 positions of the two GalpNAc residues present in each repeating unit of pneumococcal TAs (pnTAs), of which only LicD1 has been determined to be essential. At the molecular level, the specificity of the P-Cho attachment to pnTAs by LicD1 and LicD2 remains still elusive. Here, using detailed structural analyses of pnTAs from a LicD2-deficient strain, we confirmed the specificity in the attachment of P-Cho residues to pnTA. LicD1 solely transfers P-Cho to α-d-GalpNAc moieties, whereas LicD2 attaches P-Cho to β-d-GalpNAc. Further, we investigated the role of the pneumococcal phosphorylcholine esterase (Pce) in the modification of the P-Cho substitution pattern of pnTAs. To clarify the specificity of Pce-mediated P-Cho hydrolysis, we evaluated different concentrations and pH conditions for the treatment of pneumococcal lipoteichoic acid with purified Pce. We show that Pce can hydrolyze both P-Cho residues of the ...Continue Reading

References

Jan 15, 1992·European Journal of Biochemistry·J M Sanchez-PuellesE Garcia
Sep 1, 1982·Journal of Bacteriology·R LopezA Tomasz
Jan 1, 1997·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·W Fischer
Jan 1, 1997·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·A SeverinA Tomasz
Apr 14, 1999·Molecular Microbiology·J R ZhangE I Tuomanen
Sep 7, 2001·Journal of Bacteriology·J HoskinsJ I Glass
Jan 5, 2002·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·B de las RivasP García
May 17, 2005·Nature Structural & Molecular Biology·Juan A HermosoMargarita Menéndez
Jan 13, 2010·Immunity·Mirjam SchenkRobert L Modlin
Sep 3, 2011·Immunological Reviews·Matthew T Sorbara, Dana J Philpott
Mar 22, 2012·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Dalia DenapaiteWaldemar Vollmer
Oct 26, 2014·The Journal of Immunology : Official Journal of the American Association of Immunologists·Emilie Vassal-StermannNicole M Thielens

❮ Previous
Next ❯

Citations

Jul 23, 2020·BioMed Research International·Moad KhalifaWei Cun See Too
Mar 19, 2020·Microorganisms·Pierre-Alexander MückeDörte Becher
Dec 4, 2020·FEMS Microbiology Reviews·Xia WuJian Zha

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

ASBMB Publications

The American Society for Biochemistry and Molecular Biology (ASBMB) includes the Journal of Biological Chemistry, Molecular & Cellular Proteomics, and the Journal of Lipid Research. Discover the latest research from ASBMB here.